Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption
Targeting ligands on drug carriers can trigger immune responses. Here, the authors modify liposomes with a peptidomimetic that preserves bioactivity of the nanocarrier in blood circulation and attenuates IgM absorption, thereby improving the immunocompatibility of brain-targeted liposomes.
Main Authors: | Juan Guan, Qing Shen, Zui Zhang, Zhuxuan Jiang, Yang Yang, Meiqing Lou, Jun Qian, Weiyue Lu, Changyou Zhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2018-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-05384-1 |
Similar Items
-
Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
by: Hiroshi Kiwada, et al.
Published: (2010-12-01) -
Brain-targeted drug delivery by manipulating protein corona functions
by: Zui Zhang, et al.
Published: (2019-08-01) -
Polycaprolactone-collagen nanofibers loaded with dexamethasone and simvastatin as an osteoinductive and immunocompatible scaffold for bone regeneration applications
by: Hilal Ahmad Rather, et al.
Published: (2022-12-01) -
Development of immunocompatible pluripotent stem cells via CRISPR-based human leukocyte antigen engineering
by: Yeonsue Jang, et al.
Published: (2019-01-01) -
Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles
by: Maria-Argyro Karageorgou, et al.
Published: (2021-05-01)